Correction: Accelerating Influenza Research: Vaccines, Antivirals, Immunomodulators and Monoclonal Antibodies. The Manufacture of a New Wild-Type H3N2 Virus for the Human Viral Challenge Model.

[This corrects the article DOI: 10.1371/journal.pone.0145902.].

Bibliographic Details
Main Authors:	Daniel J Fullen, Nicolas Noulin, Andrew Catchpole, Hosnieh Fathi, Edward J Murray, Alex Mann, Kingsley Eze, Ganesh Balaratnam, Daryl W Borley, Anthony Gilbert, Rob Lambkin-Williams
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2016-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4900605?pdf=render

id	doaj-f3557ce9de1b494b9924c08d2166801a
record_format	Article
spelling	doaj-f3557ce9de1b494b9924c08d2166801a2020-11-25T00:41:49ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-01116e015721110.1371/journal.pone.0157211Correction: Accelerating Influenza Research: Vaccines, Antivirals, Immunomodulators and Monoclonal Antibodies. The Manufacture of a New Wild-Type H3N2 Virus for the Human Viral Challenge Model.Daniel J FullenNicolas NoulinAndrew CatchpoleHosnieh FathiEdward J MurrayAlex MannKingsley EzeGanesh BalaratnamDaryl W BorleyAnthony GilbertRob Lambkin-Williams[This corrects the article DOI: 10.1371/journal.pone.0145902.].http://europepmc.org/articles/PMC4900605?pdf=render
collection	DOAJ
language	English
format	Article
sources	DOAJ
author	Daniel J Fullen Nicolas Noulin Andrew Catchpole Hosnieh Fathi Edward J Murray Alex Mann Kingsley Eze Ganesh Balaratnam Daryl W Borley Anthony Gilbert Rob Lambkin-Williams
spellingShingle	Daniel J Fullen Nicolas Noulin Andrew Catchpole Hosnieh Fathi Edward J Murray Alex Mann Kingsley Eze Ganesh Balaratnam Daryl W Borley Anthony Gilbert Rob Lambkin-Williams Correction: Accelerating Influenza Research: Vaccines, Antivirals, Immunomodulators and Monoclonal Antibodies. The Manufacture of a New Wild-Type H3N2 Virus for the Human Viral Challenge Model. PLoS ONE
author_facet	Daniel J Fullen Nicolas Noulin Andrew Catchpole Hosnieh Fathi Edward J Murray Alex Mann Kingsley Eze Ganesh Balaratnam Daryl W Borley Anthony Gilbert Rob Lambkin-Williams
author_sort	Daniel J Fullen
title	Correction: Accelerating Influenza Research: Vaccines, Antivirals, Immunomodulators and Monoclonal Antibodies. The Manufacture of a New Wild-Type H3N2 Virus for the Human Viral Challenge Model.
title_short	Correction: Accelerating Influenza Research: Vaccines, Antivirals, Immunomodulators and Monoclonal Antibodies. The Manufacture of a New Wild-Type H3N2 Virus for the Human Viral Challenge Model.
title_full	Correction: Accelerating Influenza Research: Vaccines, Antivirals, Immunomodulators and Monoclonal Antibodies. The Manufacture of a New Wild-Type H3N2 Virus for the Human Viral Challenge Model.
title_fullStr	Correction: Accelerating Influenza Research: Vaccines, Antivirals, Immunomodulators and Monoclonal Antibodies. The Manufacture of a New Wild-Type H3N2 Virus for the Human Viral Challenge Model.
title_full_unstemmed	Correction: Accelerating Influenza Research: Vaccines, Antivirals, Immunomodulators and Monoclonal Antibodies. The Manufacture of a New Wild-Type H3N2 Virus for the Human Viral Challenge Model.
title_sort	correction: accelerating influenza research: vaccines, antivirals, immunomodulators and monoclonal antibodies. the manufacture of a new wild-type h3n2 virus for the human viral challenge model.
publisher	Public Library of Science (PLoS)
series	PLoS ONE
issn	1932-6203
publishDate	2016-01-01
description	[This corrects the article DOI: 10.1371/journal.pone.0145902.].
url	http://europepmc.org/articles/PMC4900605?pdf=render
work_keys_str_mv	AT danieljfullen correctionacceleratinginfluenzaresearchvaccinesantiviralsimmunomodulatorsandmonoclonalantibodiesthemanufactureofanewwildtypeh3n2virusforthehumanviralchallengemodel AT nicolasnoulin correctionacceleratinginfluenzaresearchvaccinesantiviralsimmunomodulatorsandmonoclonalantibodiesthemanufactureofanewwildtypeh3n2virusforthehumanviralchallengemodel AT andrewcatchpole correctionacceleratinginfluenzaresearchvaccinesantiviralsimmunomodulatorsandmonoclonalantibodiesthemanufactureofanewwildtypeh3n2virusforthehumanviralchallengemodel AT hosniehfathi correctionacceleratinginfluenzaresearchvaccinesantiviralsimmunomodulatorsandmonoclonalantibodiesthemanufactureofanewwildtypeh3n2virusforthehumanviralchallengemodel AT edwardjmurray correctionacceleratinginfluenzaresearchvaccinesantiviralsimmunomodulatorsandmonoclonalantibodiesthemanufactureofanewwildtypeh3n2virusforthehumanviralchallengemodel AT alexmann correctionacceleratinginfluenzaresearchvaccinesantiviralsimmunomodulatorsandmonoclonalantibodiesthemanufactureofanewwildtypeh3n2virusforthehumanviralchallengemodel AT kingsleyeze correctionacceleratinginfluenzaresearchvaccinesantiviralsimmunomodulatorsandmonoclonalantibodiesthemanufactureofanewwildtypeh3n2virusforthehumanviralchallengemodel AT ganeshbalaratnam correctionacceleratinginfluenzaresearchvaccinesantiviralsimmunomodulatorsandmonoclonalantibodiesthemanufactureofanewwildtypeh3n2virusforthehumanviralchallengemodel AT darylwborley correctionacceleratinginfluenzaresearchvaccinesantiviralsimmunomodulatorsandmonoclonalantibodiesthemanufactureofanewwildtypeh3n2virusforthehumanviralchallengemodel AT anthonygilbert correctionacceleratinginfluenzaresearchvaccinesantiviralsimmunomodulatorsandmonoclonalantibodiesthemanufactureofanewwildtypeh3n2virusforthehumanviralchallengemodel AT roblambkinwilliams correctionacceleratinginfluenzaresearchvaccinesantiviralsimmunomodulatorsandmonoclonalantibodiesthemanufactureofanewwildtypeh3n2virusforthehumanviralchallengemodel
_version_	1725285413708365824

Correction: Accelerating Influenza Research: Vaccines, Antivirals, Immunomodulators and Monoclonal Antibodies. The Manufacture of a New Wild-Type H3N2 Virus for the Human Viral Challenge Model.

Similar Items